Indonesia's exports of basic pharmaceutical products and pharmaceutical preparations to India have shown considerable fluctuations over the years. In 2013, the exports stood at $95.155 million, peaking in 2014 at $99.833 million. The period from 2015 to 2017 experienced a significant dip, with the value dropping to a low of $63.411 million in 2017. A recovery phase began in 2018, and by 2023, exports were valued at $74.585 million. Year-on-year variation indicated modest positive and negative shifts, with a notable decline in 2022 (-8.24%) and minor growth in 2023 (0.91%). Over the past five years, the compound annual growth rate (CAGR) was a modest 0.69%, highlighting limited consistent growth.

Future trends to watch for include:

Steady but modest growth in exports, with forecasts predicting an average annual growth rate (CAGR) of 0.6% through 2028.
Potential impact of regulatory changes and economic conditions in both Indonesia and India on trade volumes.
Shifts in global pharmaceutical demand and supply chain dynamics that could influence export trends.